Chemoinducible Virotherapy for advanced ovarian cancer
I Herrmann, M Porten, A Menzel, DT Curiel, D Niederacher, P Dall · Zentralblatt für Gynäkologie · 2005 · Heft 10
Bibliografische Angaben
Zusammenfassung
Objective of Study: Resistance of antineoplastic agents remains a barrier to the establishment of curative chemotherapy regimens for advanced ovarian cancer. Overexpression of the p-glycoprotein encoded by the MDR1 gene is known to mediate resistance to antineoplatstic drugs. We describe a chemoinducible virotherapy for chemoresistant OvCa using the MDR1 promoter controlling replication of conditionally replicating Adenovirus (CRAds). Methods: The inducibility of MDR1 by Doxorubicin (DOX) was analysed by RT-PCR and by luciferase reporter assays. Two CRAds were generated: Ad5/3mdrE1 was constructed by replacing t…